The key markers used to differentiate neuroblastomas from other round cell tumors include cytokeratins (for thymic tumors), CD45 (for lymphoid malignancies), and CD99 (for primitive neuroectodermal tumor).18). Here, CD99 is linked to primitive neuroectodermal tumor.